pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
Hubs
  • Topics
  • Patent cliff
  • Publications
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search

calendar

7,883 catalysts · 5,256 phase readout · 2,309 8k filing · 315 pdufa · 259 earnings · 2 approval · 1 adcom

★ save view↓export CSV
next 91 dayslessmore
MonWedFri
2026-07-27: 0 catalysts2026-07-28: 0 catalysts2026-07-29: 0 catalysts2026-07-30: 38 catalysts2026-07-31: 3 catalysts2026-08-01: 0 catalysts2026-08-02: 0 catalysts2026-08-03: 4 catalysts2026-08-04: 13 catalysts2026-08-05: 16 catalysts2026-08-06: 10 catalysts2026-08-07: 1 catalyst2026-08-08: 0 catalysts2026-08-09: 0 catalysts2026-08-10: 1 catalyst2026-08-11: 1 catalyst2026-08-12: 1 catalyst2026-08-13: 1 catalyst2026-08-14: 0 catalysts2026-08-15: 0 catalysts2026-08-16: 0 catalysts2026-08-17: 0 catalysts2026-08-18: 1 catalyst2026-08-19: 0 catalysts2026-08-20: 0 catalysts2026-08-21: 0 catalysts2026-08-22: 0 catalysts2026-08-23: 0 catalysts2026-08-24: 0 catalysts2026-08-25: 0 catalysts2026-08-26: 0 catalysts2026-08-27: 0 catalysts2026-08-28: 0 catalysts2026-08-29: 0 catalysts2026-08-30: 0 catalysts2026-08-31: 0 catalysts2026-09-01: 1 catalyst2026-09-02: 0 catalysts2026-09-03: 0 catalysts2026-09-04: 0 catalysts2026-09-05: 0 catalysts2026-09-06: 0 catalysts2026-09-07: 0 catalysts2026-09-08: 0 catalysts2026-09-09: 0 catalysts2026-09-10: 0 catalysts2026-09-11: 0 catalysts2026-09-12: 0 catalysts2026-09-13: 0 catalysts2026-09-14: 0 catalysts2026-09-15: 0 catalysts2026-09-16: 0 catalysts2026-09-17: 0 catalysts2026-09-18: 0 catalysts2026-09-19: 0 catalysts2026-09-20: 0 catalysts2026-09-21: 0 catalysts2026-09-22: 0 catalysts2026-09-23: 0 catalysts2026-09-24: 0 catalysts2026-09-25: 0 catalysts2026-09-26: 0 catalysts2026-09-27: 0 catalysts2026-09-28: 0 catalysts2026-09-29: 0 catalysts2026-09-30: 0 catalysts2026-10-01: 0 catalysts2026-10-02: 0 catalysts2026-10-03: 0 catalysts2026-10-04: 0 catalysts2026-10-05: 0 catalysts2026-10-06: 0 catalysts2026-10-07: 0 catalysts2026-10-08: 0 catalysts2026-10-09: 0 catalysts2026-10-10: 0 catalysts2026-10-11: 0 catalysts2026-10-12: 0 catalysts2026-10-13: 0 catalysts2026-10-14: 0 catalysts2026-10-15: 0 catalysts2026-10-16: 0 catalysts2026-10-17: 0 catalysts2026-10-18: 0 catalysts2026-10-19: 0 catalysts2026-10-20: 1 catalyst2026-10-21: 1 catalyst2026-10-22: 2 catalysts2026-10-23: 0 catalysts2026-10-24: 0 catalysts2026-10-25: 0 catalysts
view
agendamonth
show past →
sort
soonestlatesttypesponsoralpha
type
  • phase readout5,256
  • 8k filing2,309
  • pdufa315
  • earnings259
  • approval2
  • adcom1
therapy area

no tagged catalysts yet

Date TBD

50
›RECRUITINGphase readoutNCT07006012: RGL-305+ Lymphoma + Exploratory Clinical Study

Sponsor: Fudan University. Phase: NA. Conditions: Lymphoma Patients With Complete Response (CR) or Partial Response (PR) After Standard Treatment Had a Positive Minimal Residual Lesion (MRD)

full page →ctgov ↗
›ACTIVE_NOT_RECRUITINGphase readoutNCT04205812: Platinum-Based Chemotherapy With/Without INCMGA00012, an Anti-PD-1 Antibody, in Non-Small Cell Lung Cancer

Sponsor: Incyte Corporation. Phase: PHASE3. Conditions: Metastatic Squamous Non-Small Cell Lung Cancer, Metastatic Nonsquamous Non-Small Cell Lung Cancer

full page →ctgov ↗
›COMPLETEDphase readoutNCT04998812: A Study Evaluating B Cell Levels In Infants Potentially Exposed To Ocrelizumab During Pregnancy

Sponsor: Hoffmann-La Roche. Phase: PHASE4. Conditions: Multiple Sclerosis, Clinically Isolated Syndrome

full page →ctgov ↗
›COMPLETEDphase readoutNCT00076830: Evaluation and Treatment of Patients With Connective Tissue Disease

Sponsor: Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD). Phase: . Conditions: Connective Tissue Disorders, Osteogenesis Imperfecta, Bone Diseases, Metabolic, Melorheostosis

full page →ctgov ↗
›RECRUITINGphase readoutNCT06920628: PET Imaging of Cyclooxygenase-1 in Participants With Neurological Manifestations of Post-Acute Sequelae of SARS-CoV-2 Infection (PASC)

Sponsor: National Institute of Mental Health (NIMH). Phase: PHASE1. Conditions: Long COVID, Post Acute Sequelae of COVID-19

full page →ctgov ↗
›WITHDRAWNphase readoutNCT04533919: Validation of Pre-clinical Nano-Based Analgesics in Cells From Human Dorsal Root Ganglia

Sponsor: M.D. Anderson Cancer Center. Phase: . Conditions: Spinal Cord Neoplasm

full page →ctgov ↗
›RECRUITINGphase readoutNCT07348419: Quadro-Iliac vs Thoracolumbar Interfascial Plane Block for Analgesia After Single-Level Lumbar Disc Surgery

Sponsor: Samsun University. Phase: NA. Conditions: Acute Pain, Spinal Stenosis

full page →ctgov ↗
›RECRUITINGphase readoutNCT07436728: A Study of TAK-505 in Adults With Solid Tumors

Sponsor: Takeda. Phase: PHASE1. Conditions: Malignant Solid Tumors

full page →ctgov ↗
›RECRUITINGphase readoutNCT07542665: Aromatherapy vs Music Therapy for Anxiety in Children During Dental Radiography

Sponsor: Nigde Omer Halisdemir University. Phase: NA. Conditions: Dental Anxiety in Children, Pediatric Anxiety

full page →ctgov ↗
›RECRUITINGphase readoutNCT07408765: Physical Activity, Fatigue, Social Support, and Psychological Well-Being in Women With Primary Hypothyroidism

Sponsor: University of Oviedo. Phase: . Conditions: Hypothyroidism Primary

full page →ctgov ↗
›ACTIVE_NOT_RECRUITINGphase readoutNCT06476665: A Study to Learn About the Safety of BESPONSA Injection in Pediatric Patients With Acute Lymphocytic Leukemia.

Sponsor: Pfizer. Phase: . Conditions: Acute Lymphocytic Leukemia

full page →ctgov ↗
›NOT_YET_RECRUITINGphase readoutNCT07263867: Enhanced Ward Rounds for Bowel Preparation Quality in Hospitalized Patients Undergoing Colonoscopy

Sponsor: LanZhou University. Phase: NA. Conditions: Colonoscopy, Bowel Preparation, Quality of Healthcare

full page →ctgov ↗
›COMPLETEDphase readoutNCT06914167: The Effectiveness of Lavender Aromatherapy Combined With Slow Breathing Exercises in Improving Occupational Burnout and Sleep Disorders Among Nursing Staff

Sponsor: Tri-Service General Hospital (TSGH). Phase: NA. Conditions: Sleep Wake Disorders

full page →ctgov ↗
›RECRUITINGphase readoutNCT07315607: In Vivo Evaluation of the Accuracy of Immediate Screw-Retained Provisional Crowns Fabricated Using Digital Planning and Guided Surgery

Sponsor: Universidad Complutense de Madrid. Phase: NA. Conditions: Partial Edentulism, Tooth Loss / Rehabilitation

full page →ctgov ↗
›TERMINATEDphase readoutNCT05388136: Trial Comparing Different Follow-up Strategies

Sponsor: Insel Gruppe AG, University Hospital Bern. Phase: NA. Conditions: Head and Neck Cancer

full page →ctgov ↗
›ACTIVE_NOT_RECRUITINGphase readoutNCT05059236: A Study to Learn How Well Darolutamide Administered Together With Androgen Deprivation Therapy (ADT) Works in Men With Metastatic Hormone-sensitive Prostate Cancer. Results Will be Compared With ADT Alone From a Previously Conducted Study.

Sponsor: Bayer. Phase: PHASE2. Conditions: Metastatic Hormone-sensitive Prostate Cancer

full page →ctgov ↗
›RECRUITINGphase readoutNCT07344311: A Phase I Trial of A-CAR032 in Participants With mCRPC

Sponsor: Shanghai AbelZeta Ltd.. Phase: PHASE1. Conditions: Prostate Cancer, Metastatic Castration-Resistant Prostate Cancer

full page →ctgov ↗
›COMPLETEDphase readoutNCT05588011: Influence of Oxygenator Selection on Platelet Function and Rotational Thromboelastometry Following Cardiopulmonary Bypass

Sponsor: BRADEN DULONG. Phase: NA. Conditions: Platelet Dysfunction, Cardiopulmonary Bypass

full page →ctgov ↗
›COMPLETEDphase readoutNCT07161011: Phase 2b Controlled Study of Dosing Techniques - Part B

Sponsor: IVIEW Therapeutics Inc.. Phase: PHASE2. Conditions: Dry Eye

full page →ctgov ↗
›COMPLETEDphase readoutNCT04154111: Theta Burst Stimulation as a Tool to Decrease Drinking in Treatment-seeking Alcohol Users

Sponsor: Wake Forest University Health Sciences. Phase: NA. Conditions: Alcohol Use Disorder, Alcohol Abuse, Alcohol Dependence, Craving

full page →ctgov ↗
›ACTIVE_NOT_RECRUITINGphase readoutNCT05888844: A Study to Evaluate INCB099280 in Participants With Advanced Cutaneous Squamous Cell Carcinoma

Sponsor: Incyte Corporation. Phase: PHASE2. Conditions: Cutaneous Squamous Cell Carcinoma

full page →ctgov ↗
›NOT_YET_RECRUITINGphase readoutNCT07324044: Chrono-ALIGN: A Chronotype-Based Chrono-Nutrition Intervention in Post-Bariatric Patients

Sponsor: King Saud University. Phase: NA. Conditions: Obesity (Disorder), Morbid Obesity, Bariatric Sleeve Gastrectomy, Meal Time, Chronotype, Circadian Rhythm

full page →ctgov ↗
›NOT_YET_RECRUITINGphase readoutNCT07410234: Phase II Exploratory Study of Toripalimab Combined With SBRT in HER2-Negative Breast Cancer Patients With Insensitivity to Neoadjuvant Chemotherapy

Sponsor: Tianjin Medical University Cancer Institute and Hospital. Phase: PHASE2. Conditions: Breast Cancer

full page →ctgov ↗
›COMPLETEDphase readoutNCT05552664: The Genetic Information and Family Testing (GIFT) Study

Sponsor: University of Michigan Rogel Cancer Center. Phase: NA. Conditions: Cancer

full page →ctgov ↗
›RECRUITINGphase readoutNCT07311564: A Study of LAD603 in Adults With Alopecia Areata

Sponsor: Almirall, S.A.. Phase: PHASE2. Conditions: Alopecia Areata

full page →ctgov ↗
›RECRUITINGphase readoutNCT03664609: Deep Brain Stimulation (DBS) Retrospective Outcomes Study

Sponsor: Boston Scientific Corporation. Phase: . Conditions: Parkinson Disease, Essential Tremor, Dystonia

full page →ctgov ↗
›RECRUITINGphase readoutNCT07264699: Visually Guided TAP Block in Laparoscopic TAPP Hernia Repair

Sponsor: University of Warmia and Mazury in Olsztyn. Phase: NA. Conditions: Inguinal Hernia Repair, Postoperative Pain, TAP Block

full page →ctgov ↗
›COMPLETEDphase readoutNCT04341532: Bacterial Gene Profiling to Predict Antibiotic Resistance During Cystic Fibrosis Pulmonary Exacerbations

Sponsor: National Jewish Health. Phase: . Conditions: Cystic Fibrosis

full page →ctgov ↗
›RECRUITINGphase readoutNCT07262632: Developing a Multimodal Cancer Pain Database to Support AI-Based Automatic Pain Assessment

Sponsor: Dr. Mark Mulder. Phase: . Conditions: Cancer-related Pain, Pain Assessment, Artificial Intelligence (AI), Oncology, Oncology Pain, Database, Facial Expression, Voice, Cancer

full page →ctgov ↗
›ACTIVE_NOT_RECRUITINGphase readoutNCT06113198: A Study on the Immune Response and Safety of a Vaccine Against N. Meningitidis Serogroup B Infection in Healthy Infants From 2 Months of Age

Sponsor: GlaxoSmithKline. Phase: PHASE4. Conditions: Meningitis, Meningococcal

full page →ctgov ↗
›AVAILABLEphase readoutNCT04566393: Expanded Access to Ulixertinib (BVD-523) in Patients With Advanced MAPK Pathway-Altered Malignancies

Sponsor: xCures. Phase: . Conditions: Pancreatic Cancer, Small Bowel Cancer, Colorectal Cancer, Melanoma, Non Small Cell Lung Cancer, Thyroid Cancer, Bladder Cancer, Head and Neck Cancer, Gastric Cancer, Esophageal Cancer, Cholangiocarcinoma, Ovarian Cancer, Hepatocellular Carcinoma, Glioblastoma, MAPK Gene Mutation, KRAS Activating Mutation, BRAF Gene Mutation, NRAS Gene Mutation, HRAS Gene Mutation, MEK Mutation, ERK Mutation

full page →ctgov ↗
›NOT_YET_RECRUITINGphase readoutNCT07334093: A Study of Hetrombopag Combined With rhTPO in the Treatment of Cancer Therapy-induced Thrombocytopenia (CTIT) in Solid Tumor Patients.

Sponsor: Sun Yat-sen University. Phase: PHASE2. Conditions: Cancer Therapy-induced Thrombocytopenia (CTIT)

full page →ctgov ↗
›NOT_YET_RECRUITINGphase readoutNCT07301021: Velopharyngeal Insufficiency After Maxillomandibular Advancement Osteotomy in Obstructive Sleep Apnea Patients

Sponsor: Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA). Phase: . Conditions: Velopharyngeal Insufficiency, Swallowing, Nasality, Speech

full page →ctgov ↗
›RECRUITINGphase readoutNCT05837221: Microbiome in Head and Neck Squamous Cell Carcinoma

Sponsor: University of Colorado, Denver. Phase: . Conditions: Head and Neck Cancer, Lip Cancer, Oral Cancer, Pharynx Cancer

full page →ctgov ↗
›RECRUITINGphase readoutNCT07380321: Diaphragm Ultrasound İn Children With OSAS

Sponsor: Istanbul University. Phase: . Conditions: Obstructive Sleep Apnea of Child

full page →ctgov ↗
›COMPLETEDphase readoutNCT07057921: The Learning Curve of Video Laryngeal Mask Airway (Video-LMA) Use in Airway Management by Anesthesiology Residents

Sponsor: Samsun University. Phase: . Conditions: Laryngeal Mask Airways, Airway Devices

full page →ctgov ↗
›RECRUITINGphase readoutNCT07374614: Iruplinalkib in ALK-Positive Advanced Lung Adenocarcinoma After Lorlatinib

Sponsor: Peking University Shenzhen Hospital. Phase: . Conditions: Non-Small Cell Lung Cancer, ALK, Iruplinalkib, Lorlatinib, Real-world Study, Observational Study

full page →ctgov ↗
›ACTIVE_NOT_RECRUITINGphase readoutNCT07442214: View of Cerebral Perfusion in Liver Transplantation

Sponsor: Inonu University. Phase: . Conditions: End-stage Liver Disease (ESLD), Liver Transplantation, Cerebral Perfusion, Intraoperative Monitoring

full page →ctgov ↗
›COMPLETEDphase readoutNCT02957916: Vanderbilt Childhood Obesity Registry

Sponsor: Vanderbilt University Medical Center. Phase: . Conditions: Childhood Onset Obesity, Pediatric Obesity, Childhood Obesity

full page →ctgov ↗
›RECRUITINGphase readoutNCT07394816: Can Ultrasound-Guided Fascial Plane Blocks Reduce Postoperative Pulmonary Complications After Major Abdominal Surgery?

Sponsor: Dr Abdurrahman Yurtaslan Ankara Oncology Training and Research Hospital. Phase: . Conditions: Postoperative Pulmonary Complications (PPCs), Abdominal Surgeries, Postoperative Pain Management

full page →ctgov ↗
›RECRUITINGphase readoutNCT05482906: Common and Specific Information From Neuroimaging and Smartphone

Sponsor: Nantes University Hospital. Phase: . Conditions: Multiple Sclerosis

full page →ctgov ↗
›RECRUITINGphase readoutNCT06910306: Alpha Radiation Emitters Device (DaRT) for the Treatment of Recurrent Glioblastoma

Sponsor: Alpha Tau Medical LTD.. Phase: NA. Conditions: Recurrent Glioblastoma, Recurrent Gliomas

full page →ctgov ↗
›RECRUITINGphase readoutNCT07543484: Kinematics and Muscle Activity During the Tennis Serve and Musculoskeletal Characteristics in Tennis Players With Subacromial Pain Syndrome or History of Shoulder Pain

Sponsor: National Yang Ming Chiao Tung University. Phase: . Conditions: Shoulder Pain

full page →ctgov ↗
›NOT_YET_RECRUITINGphase readoutNCT07486505: Mindfulness in Fracture Recovery and Reduction of Opioid Reliance: Evaluating the Feasibility of Implementing a Brief, Mindfulness-based Intervention to Manage Pain and Anxiety Before and After Fracture Surgery

Sponsor: McMaster University. Phase: NA. Conditions: Orthopaedic Fractures, Orthopaedic Trauma Fractures and Non-unions, Orthopaedic Trauma, Orthopaedic Surgery, Orthopaedic Related Pain (Musculoskeletal Pain), Anxiety Acute, Anxiety After Surgery, Opioid Use, Opioid Use After Surgery

full page →ctgov ↗
›RECRUITINGphase readoutNCT07195994: A Clinical Trial to Examine the Efficacy and Safety of an Investigational Product With and Without Use of Semaglutide on Glycemic Response in Adults With Prediabetes or Type 2 Diabetes

Sponsor: QuickSilver Scientific. Phase: NA. Conditions: Prediabetes / Type 2 Diabetes

full page →ctgov ↗
›NOT_YET_RECRUITINGphase readoutNCT07504094: Active Coping: Interdisciplinary Program for Chronic Pain, Physiotherapy Unit (Spain)

Sponsor: Universidad de Zaragoza. Phase: NA. Conditions: Chronic Back Pain, Chronic Pain, Back Pain, Low Back Pain, Chronic, Musculoskeletal Pain, Kinesiophobia

full page →ctgov ↗
›COMPLETEDphase readoutNCT02616666: A Pragmatic Randomized Trial to Evaluate the Comparative Effectiveness Between Dapagliflozin and Standard of Care in Type 2 Diabetes Patients

Sponsor: University of Liverpool. Phase: PHASE4. Conditions: Type 2 Diabetes Mellitus

full page →ctgov ↗
›RECRUITINGphase readoutNCT07206056: An Open-label Dose Escalation and Expansion, Followed by a Phase II Study of Tulmimetostat (DZR123) and JSB462 (Luxdegalutamide) in Patients With Progressive Metastatic Castrate Resistant Prostate Cancer (mCRPC) (TulmiSTAR-01)

Sponsor: Novartis Pharmaceuticals. Phase: PHASE1. Conditions: Progressive Metastatic Castrate Resistant Prostate Cancer

full page →ctgov ↗
›ACTIVE_NOT_RECRUITINGphase readoutNCT00092222: Virotherapy and Natural History Study of KHSV-Associated Multricentric Castleman s Disease With Correlates of Disease Activity

Sponsor: National Cancer Institute (NCI). Phase: PHASE2. Conditions: Lymphoproliferative Disorder, HHV-8, Malignancy, HIV

full page →ctgov ↗
›NOT_YET_RECRUITINGphase readoutNCT07556822: Phase I Study of HRS-3005 in B-cell Malignancies

Sponsor: Jiangsu HengRui Medicine Co., Ltd.. Phase: PHASE1. Conditions: B-cell Malignancy

full page →ctgov ↗
← prev
page 62 of 158
next →